Ever Neuro Pharma GmbH   Report issue

For profit Phase 3 Phase 4
Founded: Vöcklabruck Austria (1934)
Status: No NME R&D (1934)

Organization Overview

First Clinical Trial
2004
NCT00911807
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Ever Neuro Pharma GmbH